Propofol Calculation Formula

Propofol Dosage Calculator

Calculate precise propofol dosages based on patient weight and desired sedation level. This tool follows standard anesthesia protocols for accurate medication administration.

Introduction & Importance of Propofol Dosage Calculation

Propofol (2,6-diisopropylphenol) is a short-acting intravenous anesthetic agent widely used for sedation and general anesthesia. Its rapid onset and short duration of action make it ideal for both induction and maintenance of anesthesia, as well as for sedation in intensive care units.

Medical professional preparing propofol dosage with syringe and vial showing precise measurement

Accurate propofol dosing is critical because:

  1. Patient Safety: Overdosing can lead to severe cardiovascular depression, while underdosing may result in inadequate sedation or anesthesia.
  2. Procedure Success: Proper dosing ensures smooth induction and maintenance of the desired sedation level throughout medical procedures.
  3. Recovery Time: Precise calculation helps optimize recovery times, reducing post-operative complications.
  4. Cost Efficiency: Accurate dosing minimizes drug waste, which is particularly important given propofol’s relatively high cost compared to other anesthetics.

This calculator follows evidence-based guidelines from the American Society of Anesthesiologists (ASA) and incorporates pharmacokinetic models to provide clinically relevant dosing recommendations.

How to Use This Propofol Calculator

Step-by-Step Instructions
  1. Enter Patient Weight:
    • Input the patient’s weight in kilograms (kg)
    • For pediatric patients, use actual body weight
    • For obese adults, consider using adjusted body weight (ABW) or ideal body weight (IBW) based on clinical judgment
  2. Select Sedation Level:
    • Light Sedation: Minimal depression of consciousness (e.g., minor procedures)
    • Moderate Sedation: Purposeful response to verbal/tactile stimulation (most common for procedural sedation)
    • Deep Sedation: Purposeful response only after repeated stimulation (e.g., endoscopic procedures)
    • Induction Dose: For rapid induction of general anesthesia
  3. Set Procedure Duration:
    • Enter the expected duration of the procedure in minutes
    • For procedures with uncertain duration, estimate conservatively
    • The calculator will adjust maintenance rates accordingly
  4. Choose Propofol Concentration:
    • Select either 10 mg/mL (1%) or 20 mg/mL (2%) concentration
    • 20 mg/mL is more commonly used in clinical practice
    • The calculator will automatically adjust volume calculations
  5. Review Results:
    • The calculator provides four key metrics:
      1. Initial bolus dose (mg)
      2. Maintenance infusion rate (mg/kg/hr)
      3. Total volume needed (mL)
      4. Infusion rate in mL/hr for pump programming
    • An interactive chart visualizes the dosing regimen over time
    • Always verify calculations with clinical judgment
Clinical Considerations

While this calculator provides evidence-based recommendations, always consider:

  • Patient’s age, comorbidities, and medication history
  • Concurrent use of other sedatives or analgesics
  • Hemodynamic status and monitoring capabilities
  • Institutional protocols and guidelines
  • The need for dose adjustments in special populations (e.g., elderly, hepatic impairment)

Propofol Dosage Formula & Methodology

The calculator uses a modified Marsh model for propofol pharmacokinetics, which is widely accepted in clinical practice. The core formulas are:

1. Bolus Dose Calculation

The initial bolus dose is calculated based on the desired sedation level:

Sedation Level Bolus Dose (mg/kg) Clinical Application
Light Sedation 0.5 – 1.0 Minimal depression of consciousness
Moderate Sedation 1.0 – 1.5 Purposeful response to verbal/tactile stimulation
Deep Sedation 1.5 – 2.0 Purposeful response only after repeated stimulation
Induction 2.0 – 2.5 Rapid induction of general anesthesia
2. Maintenance Infusion Calculation

The maintenance infusion rate is calculated using the formula:

Maintenance Rate (mg/kg/hr) = Base Rate × Sedation Factor × Duration Adjustment

Where:

  • Base Rate: 100 mcg/kg/min (6 mg/kg/hr) for standard maintenance
  • Sedation Factor:
    • Light: 0.7
    • Moderate: 1.0
    • Deep: 1.3
  • Duration Adjustment:
    • Short procedures (<30 min): 1.1
    • Medium procedures (30-120 min): 1.0
    • Long procedures (>120 min): 0.9
3. Volume and Infusion Rate Calculations

The total volume required is calculated by:

Total Volume (mL) = (Bolus Dose + (Maintenance Rate × Duration/60)) / Concentration

The infusion rate in mL/hr is calculated by:

Infusion Rate (mL/hr) = (Maintenance Rate × Weight) / Concentration

Pharmacokinetic Considerations

Propofol follows a three-compartment model:

Compartment Half-life Clinical Significance
Central (Plasma) 2-8 minutes Rapid onset of action
Peripheral (Fast) 30-60 minutes Initial redistribution
Peripheral (Slow) 4-7 hours Prolonged infusion effects

These pharmacokinetic properties explain why:

  • Propofol has rapid onset (30-60 seconds)
  • Duration of action is 5-10 minutes after bolus
  • Context-sensitive half-time increases with prolonged infusion
  • Recovery is typically rapid even after prolonged infusion

Real-World Propofol Dosage Examples

These case studies demonstrate how the calculator applies to different clinical scenarios:

Case Study 1: Moderate Sedation for Colonoscopy
  • Patient: 70 kg male, ASA II, no significant comorbidities
  • Procedure: Diagnostic colonoscopy (expected duration: 30 minutes)
  • Sedation Level: Moderate
  • Calculator Inputs:
    • Weight: 70 kg
    • Sedation: Moderate
    • Duration: 30 min
    • Concentration: 20 mg/mL
  • Calculator Outputs:
    • Bolus Dose: 105 mg (1.5 mg/kg)
    • Maintenance Rate: 420 mg/hr (6 mg/kg/hr)
    • Total Volume: 8.05 mL
    • Infusion Rate: 21 mL/hr
  • Clinical Application:
    • Administer 105 mg (5.25 mL) bolus over 1-2 minutes
    • Start maintenance infusion at 21 mL/hr (420 mg/hr)
    • Monitor for adequate sedation depth and adjust as needed
    • Expect rapid recovery (5-10 minutes) after procedure completion
Case Study 2: Deep Sedation for ERCP
  • Patient: 85 kg female, ASA III, controlled hypertension
  • Procedure: Endoscopic retrograde cholangiopancreatography (ERCP) (expected duration: 90 minutes)
  • Sedation Level: Deep
  • Calculator Inputs:
    • Weight: 85 kg
    • Sedation: Deep
    • Duration: 90 min
    • Concentration: 10 mg/mL
  • Calculator Outputs:
    • Bolus Dose: 144.5 mg (1.7 mg/kg)
    • Maintenance Rate: 663 mg/hr (7.8 mg/kg/hr)
    • Total Volume: 22.7 mL
    • Infusion Rate: 66.3 mL/hr
  • Clinical Considerations:
    • Use adjusted body weight if BMI > 30 (ABW = IBW + 0.4 × (Actual Weight – IBW))
    • Monitor closely for respiratory depression given deep sedation level
    • Consider reducing maintenance rate by 20-30% after first hour due to accumulation
    • Have advanced airway equipment available
Case Study 3: Induction for General Anesthesia
  • Patient: 68 kg male, ASA I, no comorbidities
  • Procedure: Elective laparoscopic cholecystectomy
  • Sedation Level: Induction
  • Calculator Inputs:
    • Weight: 68 kg
    • Sedation: Induction
    • Duration: 120 min (maintenance phase)
    • Concentration: 20 mg/mL
  • Calculator Outputs:
    • Bolus Dose: 153 mg (2.25 mg/kg)
    • Maintenance Rate: 408 mg/hr (6 mg/kg/hr)
    • Total Volume: 13.8 mL (bolus) + 20.4 mL (maintenance) = 34.2 mL
    • Infusion Rate: 20.4 mL/hr
  • Clinical Protocol:
    • Pre-oxygenate with 100% O₂ for 3-5 minutes
    • Administer bolus over 20-30 seconds while monitoring for apnea
    • Assist ventilation as needed during induction
    • Transition to maintenance infusion after successful intubation
    • Consider adding opioid (e.g., fentanyl 1-2 mcg/kg) for analgesia
Anesthesiologist monitoring patient during propofol administration with ECG and vital signs display

Propofol Dosage Data & Clinical Statistics

The following tables present comparative data on propofol dosing across different clinical scenarios and patient populations:

Table 1: Propofol Dosage by Procedure Type
Procedure Type Typical Bolus (mg/kg) Maintenance Range (mg/kg/hr) Typical Duration Recovery Time
Upper Endoscopy 1.0-1.5 25-75 mcg/kg/min 10-30 min 5-15 min
Colonoscopy 1.0-1.5 25-100 mcg/kg/min 20-45 min 10-20 min
ERCP 1.5-2.0 50-100 mcg/kg/min 30-90 min 15-30 min
Bronchoscopy 1.0-1.5 50-75 mcg/kg/min 15-45 min 10-20 min
Elective Intubation 2.0-2.5 100-200 mcg/kg/min 5-10 min (induction) 5-10 min
ICU Sedation 0.5-1.0 (load) 5-50 mcg/kg/min Hours to days 30-60 min
Table 2: Propofol Pharmacokinetics by Age Group
Age Group Clearance (mL/kg/min) Volume of Distribution (L/kg) Elimination Half-life Dosing Adjustment
Neonates 20-30 0.5-0.7 4-7 hours Reduce by 20-30%
Infants (1-12 mo) 30-40 0.7-1.0 3-5 hours Reduce by 10-20%
Children (1-10 y) 30-35 1.0-1.5 2-3 hours Standard dosing
Adolescents (11-16 y) 25-30 1.5-2.0 1.5-2.5 hours Standard dosing
Adults (17-65 y) 20-30 2.0-3.0 0.5-1.5 hours Standard dosing
Elderly (>65 y) 15-20 1.5-2.5 1-2 hours Reduce by 20-40%

Data sources:

Expert Tips for Safe Propofol Administration

Pre-Administration Checklist
  1. Patient Assessment:
    • Verify NPO status (typically NPO ×8 hours)
    • Assess airway (Mallampati score, neck mobility)
    • Review allergies (especially egg/soy – propofol contains soybean oil)
    • Check for contraindications (hypersensitivity, lipid metabolism disorders)
  2. Equipment Preparation:
    • Ensure working suction and airway equipment
    • Prepare emergency drugs (epinephrine, atropine, vasopressors)
    • Verify monitoring (ECG, SpO₂, NIBP, EtCO₂ if available)
    • Have reversal agents available (flumazenil, naloxone)
  3. Drug Preparation:
    • Use sterile technique when drawing up propofol
    • Label syringes clearly with concentration and date/time
    • Check for precipitation or discoloration (propofol should be white)
    • Use within 6 hours of drawing up (12 hours if refrigerated)
Administration Techniques
  • Bolus Administration:
    • Administer slowly (over 20-30 seconds) to avoid apnea
    • Titrate to effect – watch for eyelash reflex disappearance
    • For induction, may need to administer in divided doses (e.g., 40 mg q10sec)
    • Expect onset within 30-60 seconds
  • Infusion Management:
    • Start infusion immediately after bolus for maintenance
    • Use infusion pump for precise delivery
    • Adjust rate every 5-10 minutes based on sedation depth
    • For prolonged infusions (>24hr), consider reducing rate by 10-20% every 4 hours
  • Monitoring Parameters:
    • Continuous SpO₂ and ECG monitoring
    • Blood pressure every 3-5 minutes during induction
    • Respiratory rate and EtCO₂ if available
    • Sedation depth using validated scale (e.g., RASS, Ramsay)
Special Populations
  • Obese Patients:
    • Use adjusted body weight for dosing calculations
    • ABW = IBW + 0.4 × (Actual Weight – IBW)
    • Consider lean body weight for very obese patients (BMI > 40)
    • Monitor closely for prolonged sedation due to increased volume of distribution
  • Elderly Patients:
    • Reduce initial bolus by 20-30%
    • Start maintenance infusion at lower end of range
    • Increase monitoring frequency due to reduced clearance
    • Be prepared for longer recovery times
  • Pediatric Patients:
    • Use weight-based dosing with maximum single dose of 1 mg/kg
    • For infants <3 months, consider 0.5 mg/kg initial dose
    • Monitor closely for bradycardia (especially with rapid bolus)
    • Use age-appropriate monitoring and airway equipment
  • Patients with Hepatic Impairment:
    • Reduce maintenance infusion rate by 25-50%
    • Extend dosing intervals
    • Monitor for prolonged sedation effects
    • Consider alternative agents for severe liver disease
Emergency Management
  1. Hypotension:
    • Reduce or stop infusion
    • Administer IV fluids (500 mL bolus)
    • Consider vasopressors (phenylephrine 40-100 mcg IV)
    • Place in Trendelenburg position if severe
  2. Apnea/Hypoventilation:
    • Stop infusion immediately
    • Provide manual ventilation with 100% O₂
    • Consider advanced airway if needed
    • Monitor EtCO₂ if available
  3. Allergic Reaction:
    • Stop infusion and administer epinephrine (0.3-0.5 mg IM)
    • Provide IV fluids and consider antihistamines/steroids
    • Monitor for anaphylaxis (bronchospasm, hypotension)
    • Have emergency response team available
  4. Accidental Overdose:
    • Stop infusion and provide supportive care
    • Monitor cardiovascular and respiratory status closely
    • Consider lipid emulsion therapy for severe toxicity
    • Consult poison control or medical toxicology

Interactive Propofol FAQ

Why does propofol cause pain on injection and how can it be prevented?

Propofol pain on injection occurs due to:

  • Activation of the kinin system causing local irritation
  • Direct irritation of venous endothelium
  • Difference in osmolality between propofol and blood

Prevention strategies:

  1. Use larger veins (antecubital fossa preferred over hand veins)
  2. Administer lidocaine (0.5-1 mg/kg) before or mixed with propofol
  3. Use propofol formulations with lipid emulsions that reduce pain
  4. Administer slowly (over 20-30 seconds)
  5. Consider pre-treatment with opioid (e.g., fentanyl 1 mcg/kg)

Note: Mixing lidocaine with propofol should be done immediately before administration as the mixture is only stable for 6 hours.

What are the signs of propofol overdose and how is it treated?

Signs of propofol overdose include:

  • Cardiovascular: Severe hypotension, bradycardia, asystole
  • Respiratory: Apnea, respiratory depression, hypoxia
  • Neurological: Prolonged unconsciousness, seizures (rare)
  • Metabolic: Lactic acidosis, hypertriglyceridemia

Treatment protocol:

  1. Immediate Actions:
    • Stop propofol infusion
    • Provide 100% oxygen via bag-valve-mask
    • Establish IV access if not already present
    • Monitor ECG, SpO₂, and blood pressure continuously
  2. Cardiovascular Support:
    • IV fluid bolus (20 mL/kg crystalloid)
    • Vasopressors (epinephrine or phenylephrine) for persistent hypotension
    • Atropine (0.5-1 mg) for bradycardia
  3. Respiratory Support:
    • Assist ventilation as needed
    • Consider advanced airway (ETT or LMA) if prolonged apnea
    • Monitor EtCO₂ if available
  4. Advanced Therapies:
    • Lipid emulsion therapy (20% lipid emulsion 1.5 mL/kg bolus, then 0.25 mL/kg/min)
    • Consider extracorporeal membrane oxygenation (ECMO) for refractory cases
    • Consult medical toxicology for severe overdoses
  5. Monitoring:
    • Continuous cardiac monitoring for at least 6 hours
    • Frequent arterial blood gases for severe cases
    • Serial electrolytes and triglyceride levels

Prognosis is generally good with prompt supportive care, as propofol is rapidly metabolized.

How does propofol compare to other sedative agents like midazolam or dexmedetomidine?
Characteristic Propofol Midazolam Dexmedetomidine
Onset of Action 30-60 seconds 1-5 minutes 5-10 minutes
Duration of Action 5-10 minutes 15-80 minutes 2-3 hours
Sedation Quality Deep, amnestic Anxiolytic, amnestic Cooperative, arousable
Respiratory Depression Significant Moderate Minimal
Hemodynamic Effects Hypotension common Minimal change Bradycardia, hypotension
Metabolism Hepatic (rapid) Hepatic (slower) Hepatic (extensive)
Ideal Procedures Short procedures, rapid recovery needed Anxiolysis, premedication Long procedures, ICU sedation
Cost Moderate Low High

Clinical selection considerations:

  • Choose propofol for procedures requiring deep sedation with rapid recovery
  • Select midazolam when anxiolysis is the primary goal or for premedication
  • Use dexmedetomidine for procedures where cooperative sedation is desired or for ICU sedation
  • Combination therapy (e.g., propofol + dexmedetomidine) can provide balanced sedation with reduced side effects
What are the long-term effects of prolonged propofol infusion?

Prolonged propofol infusion (>48 hours) may lead to several complications:

  1. Propofol Infusion Syndrome (PRIS):
    • Rare but potentially fatal condition
    • Characterized by metabolic acidosis, rhabdomyolysis, hyperkalemia, renal failure, and cardiac arrhythmias
    • Risk factors: high doses (>4 mg/kg/hr for >48hr), severe illness, young age, inadequate carbohydrate intake
    • Treatment: immediate discontinuation of propofol, supportive care, possible hemodialysis
  2. Hypertriglyceridemia:
    • Due to lipid emulsion vehicle (10% soybean oil)
    • Monitor triglyceride levels with prolonged infusion (>24 hours)
    • Consider alternative sedation if triglycerides >500 mg/dL
  3. Infection Risk:
    • Propofol supports bacterial growth (especially Serratia marcescens)
    • Strict aseptic technique required
    • Discard open vials after 6-12 hours
    • Use single-dose vials when possible
  4. Neurocognitive Effects:
    • Prolonged sedation may lead to delirium, especially in elderly
    • Daily sedation interruptions recommended for ICU patients
    • Monitor for withdrawal symptoms after prolonged infusion
  5. Tolerance and Dependence:
    • Rapid tolerance can develop with prolonged use
    • Abrupt discontinuation may cause withdrawal symptoms
    • Taper infusion gradually when discontinuing long-term sedation

Recommendations for prolonged infusion:

  • Limit duration to <72 hours when possible
  • Keep infusion rate <4 mg/kg/hr
  • Monitor triglycerides, electrolytes, and acid-base status
  • Consider alternative sedation agents for long-term use
  • Implement daily sedation vacations to assess neurological status
How should propofol be administered for procedural sedation in children?

Pediatric propofol administration requires special considerations:

Age Group Initial Bolus (mg/kg) Maintenance (mcg/kg/min) Maximum Single Dose Special Considerations
<3 months 0.5-1.0 50-100 1 mg/kg High risk of bradycardia; have atropine available
3-12 months 1.0-1.5 100-150 2 mg/kg Monitor closely for apnea
1-3 years 1.5-2.0 100-200 3 mg/kg Use weight-based dosing carefully
4-10 years 2.0-2.5 100-200 4 mg/kg Standard adult monitoring protocols
11-16 years 1.5-2.5 50-150 5 mg/kg Approach adult dosing but monitor closely

Pediatric-specific protocols:

  1. Pre-sedation:
    • Verify NPO status (clear liquids ×2hr, breast milk ×4hr, solids ×6hr)
    • Assess airway and review history of sleep apnea
    • Have age-appropriate equipment (ETT, LMAs, bags) available
  2. Administration:
    • Use smaller veins (22-24G) but expect more pain on injection
    • Consider pre-treatment with lidocaine (0.5 mg/kg, max 20 mg)
    • Administer bolus over 30-60 seconds to avoid apnea
    • Use infusion pumps for maintenance to ensure precise dosing
  3. Monitoring:
    • Continuous pulse oximetry and ECG
    • Blood pressure every 3-5 minutes during induction
    • Capnography strongly recommended if available
    • Use pediatric sedation scales (e.g., University of Michigan Sedation Scale)
  4. Recovery:
    • Monitor in recovery area until fully awake and stable
    • Assess for post-sedation agitation (common in preschool age)
    • Verify ability to maintain airway and protective reflexes before discharge
    • Provide clear post-sedation instructions to caregivers

Contraindications for pediatric propofol:

  • Age <3 months in non-ICU settings
  • Known allergy to propofol or components
  • Severe cardiac or respiratory compromise
  • Inability to secure airway if needed
What are the current controversies and research directions in propofol use?

Several controversies and active research areas exist regarding propofol use:

  1. Neurotoxicity in Developing Brains:
    • Preclinical studies suggest potential neurotoxicity in developing brains
    • FDA warning about repeated/anesthesia in children <3 years and pregnant women
    • Ongoing studies (e.g., GAS, PANDA, MASK) investigating long-term effects
    • Current recommendation: avoid elective procedures requiring anesthesia in children <3 years when possible
  2. Propofol vs. Dexmedetomidine for ICU Sedation:
    • Propofol allows faster waking for neurological exams
    • Dexmedetomidine associated with less delirium and better sleep patterns
    • Recent studies suggest dexmedetomidine may reduce ICU length of stay
    • Combination therapy being investigated for balanced sedation
  3. Optimal Sedation for Mechanical Ventilation:
    • Daily sedation interruptions vs. continuous light sedation
    • Propofol’s short half-life makes it ideal for sedation vacations
    • Protocolized sedation algorithms showing promise in reducing ventilator days
  4. Propofol in Obesity:
    • Debate over using actual vs. adjusted vs. ideal body weight
    • Recent pharmacokinetic studies suggest adjusted body weight may be most accurate
    • Concerns about underdosing with IBW vs. overdosing with ABW
  5. Alternative Formulations:
    • Fospropofol (water-soluble prodrug) in development
    • Potential for reduced pain on injection and infection risk
    • Investigation of propofol formulations with different lipid emulsions
  6. Propofol for Status Epilepticus:
    • Emerging use as third-line agent for refractory status epilepticus
    • Dosing protocols still being optimized
    • Concerns about PRIS with high-dose, prolonged infusions
  7. Environmental Impact:
    • Propofol metabolism contributes to greenhouse gas emissions
    • Research into more environmentally friendly anesthetics
    • Balancing clinical efficacy with environmental considerations

Future directions in propofol research:

  • Personalized dosing based on pharmacogenetic testing
  • Closed-loop anesthesia delivery systems using EEG monitoring
  • Development of propofol formulations with reduced side effects
  • Investigation of propofol’s potential neuroprotective effects
  • Studies on long-term cognitive effects of propofol sedation
What are the legal and documentation requirements for propofol administration?

Propofol administration has specific legal and documentation requirements:

  1. Prescriptive Authority:
    • In most jurisdictions, propofol can only be administered by or under the direct supervision of an anesthesiologist
    • Some states allow properly trained non-anesthesiologists (e.g., gastroenterologists, emergency physicians) to administer propofol for procedural sedation
    • Requires specific credentialing and privileging in most hospitals
    • Must comply with state medical board regulations
  2. Informed Consent:
    • Must document discussion of risks, benefits, and alternatives
    • Specific risks to mention: respiratory depression, hypotension, allergic reaction
    • For pediatric patients, consent from parent/guardian required
    • Documentation should include patient’s questions and understanding
  3. Pre-Procedure Documentation:
    • Complete pre-sedation assessment (history, physical, NPO status)
    • Document airway assessment (Mallampati score, neck mobility)
    • Record vital signs and baseline neurological status
    • Note any allergies or previous adverse reactions to anesthesia
  4. Intra-Procedure Documentation:
    • Record exact doses and times of all medications administered
    • Document vital signs every 3-5 minutes during induction and every 5-15 minutes during maintenance
    • Note any adverse events and interventions
    • Record sedation depth using validated scale
  5. Post-Procedure Requirements:
    • Document recovery vital signs and neurological status
    • Record time to discharge readiness (e.g., Aldrete score ≥9)
    • Provide and document post-sedation instructions
    • Note any complications during recovery
  6. Quality Assurance:
    • Many institutions require peer review of sedation cases
    • Adverse events must be reported through hospital incident reporting system
    • Regular audits of sedation practices may be required
    • Continuing education in sedation techniques often mandatory

Sample documentation template:

[Date/Time] Propofol administered by [Provider Name] under supervision of [Supervising Physician]
Indication: [Procedure Name]
Pre-sedation assessment: [Details]
Initial dose: [X] mg ([Y] mg/kg) at [Time]
Maintenance infusion: [X] mcg/kg/min started at [Time], adjusted to [X] mcg/kg/min at [Time]
Total dose: [X] mg over [Y] minutes
Monitoring: Continuous SpO₂, ECG, BP q3min ×15min then q5min
Adverse events: [None or describe]
Recovery: Uneventful, discharged at [Time] with [Caregiver Name]
Post-sedation instructions provided: [Details]

Legal considerations:

  • Propofol administration without proper credentialing may constitute practicing medicine without a license
  • Inadequate monitoring or documentation can lead to malpractice liability
  • Must comply with hospital bylaws and state regulations
  • Proper documentation is essential for medicolegal protection

Leave a Reply

Your email address will not be published. Required fields are marked *